Right ventricular function and vasoactive peptides for early prediction of bronchopulmonary dysplasia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 29 01 2021
accepted: 03 09 2021
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 24 11 2021
Statut: epublish

Résumé

To assess the prognostic value of early echocardiographic indices of right ventricular function and vasoactive peptides for prediction of bronchopulmonary dysplasia (BPD) or death in very preterm infants. Prospective study involving 294 very preterm infants (median [IQR] gestational age 28.4 [26.4-30.4] weeks, birth weight 1065 [800-1380] g), of whom 57 developed BPD (oxygen supplementation at 36 weeks postmenstrual age) and 10 died. Tricuspid annular plane systolic excursion (TAPSE), right ventricular index of myocardial performance (RIMP), plasma concentrations of mid-regional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-endothelin-1 (CT-proET1) were measured on day 7 of life. RIMP was significantly increased (median [IQR] 0.3 [0.23-0.38] vs 0.22 [0.15-0.29]), TAPSE decreased (median [IQR] 5.0 [5.0-6.0] vs 6.0 [5.4-7.0] mm), MR-proANP increased (median [IQR] 784 [540-936] vs 353 [247-625] pmol/L), and CT-proET1 increased (median [IQR] 249 [190-345] vs 199 [158-284] pmol/L) in infants who developed BPD or died, as compared to controls. All variables showed significant but weak correlations with each other (rS -0.182 to 0.359) and predicted BPD/death with similar accuracy (areas under receiver operator characteristic curves 0.62 to 0.77). Multiple regression revealed only RIMP and birth weight as independent predictors of BPD or death. Vasoactive peptide concentrations and echocardiographic assessment employing standardized measures, notably RIMP, on day 7 of life are useful to identify preterm infants at increased risk for BPD or death.

Sections du résumé

BACKGROUND
To assess the prognostic value of early echocardiographic indices of right ventricular function and vasoactive peptides for prediction of bronchopulmonary dysplasia (BPD) or death in very preterm infants.
METHODS
Prospective study involving 294 very preterm infants (median [IQR] gestational age 28.4 [26.4-30.4] weeks, birth weight 1065 [800-1380] g), of whom 57 developed BPD (oxygen supplementation at 36 weeks postmenstrual age) and 10 died. Tricuspid annular plane systolic excursion (TAPSE), right ventricular index of myocardial performance (RIMP), plasma concentrations of mid-regional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-endothelin-1 (CT-proET1) were measured on day 7 of life.
RESULTS
RIMP was significantly increased (median [IQR] 0.3 [0.23-0.38] vs 0.22 [0.15-0.29]), TAPSE decreased (median [IQR] 5.0 [5.0-6.0] vs 6.0 [5.4-7.0] mm), MR-proANP increased (median [IQR] 784 [540-936] vs 353 [247-625] pmol/L), and CT-proET1 increased (median [IQR] 249 [190-345] vs 199 [158-284] pmol/L) in infants who developed BPD or died, as compared to controls. All variables showed significant but weak correlations with each other (rS -0.182 to 0.359) and predicted BPD/death with similar accuracy (areas under receiver operator characteristic curves 0.62 to 0.77). Multiple regression revealed only RIMP and birth weight as independent predictors of BPD or death.
CONCLUSIONS
Vasoactive peptide concentrations and echocardiographic assessment employing standardized measures, notably RIMP, on day 7 of life are useful to identify preterm infants at increased risk for BPD or death.

Identifiants

pubmed: 34550991
doi: 10.1371/journal.pone.0257571
pii: PONE-D-21-03203
pmc: PMC8457497
doi:

Substances chimiques

Endothelin-1 0
Atrial Natriuretic Factor 85637-73-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0257571

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Cardiovasc Ultrasound. 2017 Dec;25(4):124-130
pubmed: 29333219
Pediatrics. 2006 Jul;118(1):108-13
pubmed: 16818555
Neonatology. 2011;100(1):85-92
pubmed: 21273793
Clin Perinatol. 2015 Dec;42(4):839-55
pubmed: 26593082
Clin Chem. 2006 Jun;52(6):1144-51
pubmed: 16627560
Pediatrics. 2011 Sep;128(3):e545-9
pubmed: 21824875
Neonatology. 2016;109(4):289-96
pubmed: 26886137
Early Hum Dev. 2014 Dec;90(12):829-35
pubmed: 25463828
PLoS One. 2015 Oct 09;10(10):e0140079
pubmed: 26452045
Eur Respir J. 2008 Aug;32(2):503-12
pubmed: 18669790
JAMA. 2015 Sep 8;314(10):1039-51
pubmed: 26348753
Pediatr Res. 2003 Jun;53(6):927-32
pubmed: 12621095
Pediatrics. 1988 Oct;82(4):527-32
pubmed: 3174313
Am J Respir Crit Care Med. 2015 Jan 1;191(1):87-95
pubmed: 25389562
Clin Chem. 2004 Jan;50(1):234-6
pubmed: 14709661
PLoS One. 2012;7(6):e38352
pubmed: 22675548
J Am Soc Echocardiogr. 2015 Sep;28(9):1045-52
pubmed: 26025727
Semin Neonatol. 2003 Feb;8(1):73-81
pubmed: 12667832
Neonatology. 2015;108(4):293-6
pubmed: 26355291
Pediatr Cardiol. 2019 Jun;40(5):973-979
pubmed: 30937503
Echo Res Pract. 2020 Feb 27;7(1):G19-G41
pubmed: 32105053
J Pediatr. 2014 Nov;165(5):909-14.e1
pubmed: 25189821
Am J Perinatol. 2011 Feb;28(2):129-36
pubmed: 20700864
Pediatrics. 2010 Sep;126(3):443-56
pubmed: 20732945
Semin Perinatol. 2013 Apr;37(2):124-31
pubmed: 23582967
BMC Pulm Med. 2017 Jun 30;17(1):97
pubmed: 28666441
Front Pediatr. 2020 Jan 17;7:556
pubmed: 32010652
Respir Res. 2001;2(2):90-101
pubmed: 11686871
Lancet Child Adolesc Health. 2018 May;2(5):350-359
pubmed: 30169268
JAMA Pediatr. 2017 Mar 6;171(3):e164396
pubmed: 28068438
Pediatr Pulmonol. 1990;9(3):152-61
pubmed: 2148977
J Perinatol. 2020 Apr;40(4):607-615
pubmed: 31925319
J Am Soc Echocardiogr. 2010 May;23(5):465-95; quiz 576-7
pubmed: 20451803
J Am Soc Echocardiogr. 1996 Nov-Dec;9(6):838-47
pubmed: 8943444
J Perinatol. 2005 Jan;25(1):41-6
pubmed: 15538399
Nat Rev Dis Primers. 2019 Nov 14;5(1):78
pubmed: 31727986

Auteurs

Roland P Neumann (RP)

Department of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.

Sven M Schulzke (SM)

Department of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.

Christian Pohl (C)

Department of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.

Sven Wellmann (S)

Department of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Department of Neonatology, University Regensburg Children's Hospital (KUNO), University of Regensburg, Regensburg, Germany.

Boris Metze (B)

Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Ann-Katrin Burdensky (AK)

Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Vinzenz Boos (V)

Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Neonatology, Hospital Zollikerberg, Zollikerberg, Switzerland.

Payman Barikbin (P)

Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Pediatrics, Vivantes Hospital Friedrichshain, Berlin, Germany.

Christoph Bührer (C)

Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Christoph Czernik (C)

Department of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH